Profluent debuts to design proteins with machine learning in bid to move past 'AI sprinkled on top'
While OpenAI’s Microsoft-allied ChatGPT takes the world by storm, a fledgling startup in Berkeley, CA is debuting to take a similar language-learning model approach, but with the goal of designing new proteins.
Profluent, founded by a former Salesforce AI research leader, has secured $9 million to kick-start its work, with proceeds going toward building out an integrated wet lab and recruiting machine learning scientists and biologists. Insight Partners led the seed round. The investor base also includes Air Street Capital, AIX Ventures and Phoenix Venture Partners.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,600+ biopharma pros reading Endpoints daily — and it's free.